secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2026-08-06T11:11:10+00:00
Accession:  0001819790-26-000062
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus Pharmaceuticals raises $125M in oversubscribed PIPE financing at $56/share
--------------------------------------------------------------------------------

- Gross proceeds of ~$125M from sale of 2,098,519 shares at $56.00 and pre-funded warrants for 133,625 shares at $55.9999.
- PIPE includes participation from Alkeus investors (TCGX, Bain Capital, Wellington) and new investors (ADAR1, Sirenia, RTW, Vestal Point).
- Proceeds to fund clinical development, commercial activities, and general corporate purposes; closing expected Aug 7, 2026.
- PIPE is in connection with pending acquisition of Alkeus Pharmaceuticals (announced separately).
- Barclays lead placement agent; BofA Securities and William Blair co-placement agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979026000062/0001819790-26-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979026000062/tars-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001819790-26-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer